Abstract
This paper describes the inhibitory activities of diacylglyceride phospholipids, such as phosphatidylcholine (lecithin), phosphatidylethanolamine (cephalin), phosphatidylserine, phosphatidylglycerol, bisphosphatidylglycerol (cardiolipin), phosphatidylinositol, and phosphatidic acid (phosphatidate) (compounds 1–7, respectively) against DNA polymerase (pol), DNA topoisomerase (topo), and human cancer cell growth. Among the compounds tested, compounds 3–7 were revealed to be potent inhibitors of animal pols: compound 4 was the strongest inhibitor, with IC50 values for different pols of 1.7 – 15 μM. Compounds 4–7 also inhibited the activity of human topo II: compound 7 was the strongest inhibitor, with an IC50 value of 20 μM. The glycerophospholipids had no effect on the activities of plant (cauliflower) pol α, prokaryotic pols, or other DNA metabolic enzymes, such as calf primase of pol α, T7 RNA polymerase, T4 polynucleotide kinase, and bovine deoxyribonuclease I. These results suggest that compounds 4–7 are selective inhibitors of animal pols and human topos. Compounds 4 and 7 also suppressed the growth of a human colon carcinoma cell line that lacked p53 (HCT116 p53-/-); their LD50 values were 63.6 and 51.1 μM, respectively, suggesting that cell growth inhibition by these compounds leads to the inhibition of pols and/or topos. From these findings, diacylglyceride phospholipids, which are present in various foods, might be effective nutrients for promoting human anti-cancer health promotion.
Keywords: Diacylglyceride phospholipids, Phosphatidylglycerol, Phosphatidic acid (Phosphatidate), Enzyme inhibitor, DNA polymerase, DNA topoisomerase, Cancer cell growth suppression
Medicinal Chemistry
Title: Inhibitory Effects of Diacylglyceride Phospholipids on DNA Polymerase and Topoisomerase Activities, and Human Cancer Cell Growth
Volume: 6 Issue: 3
Author(s): Chisato Ishimaru, Toshifumi Takeuchi, Fumio Sugawara, Hiromi Yoshida and Yoshiyuki Mizushina
Affiliation:
Keywords: Diacylglyceride phospholipids, Phosphatidylglycerol, Phosphatidic acid (Phosphatidate), Enzyme inhibitor, DNA polymerase, DNA topoisomerase, Cancer cell growth suppression
Abstract: This paper describes the inhibitory activities of diacylglyceride phospholipids, such as phosphatidylcholine (lecithin), phosphatidylethanolamine (cephalin), phosphatidylserine, phosphatidylglycerol, bisphosphatidylglycerol (cardiolipin), phosphatidylinositol, and phosphatidic acid (phosphatidate) (compounds 1–7, respectively) against DNA polymerase (pol), DNA topoisomerase (topo), and human cancer cell growth. Among the compounds tested, compounds 3–7 were revealed to be potent inhibitors of animal pols: compound 4 was the strongest inhibitor, with IC50 values for different pols of 1.7 – 15 μM. Compounds 4–7 also inhibited the activity of human topo II: compound 7 was the strongest inhibitor, with an IC50 value of 20 μM. The glycerophospholipids had no effect on the activities of plant (cauliflower) pol α, prokaryotic pols, or other DNA metabolic enzymes, such as calf primase of pol α, T7 RNA polymerase, T4 polynucleotide kinase, and bovine deoxyribonuclease I. These results suggest that compounds 4–7 are selective inhibitors of animal pols and human topos. Compounds 4 and 7 also suppressed the growth of a human colon carcinoma cell line that lacked p53 (HCT116 p53-/-); their LD50 values were 63.6 and 51.1 μM, respectively, suggesting that cell growth inhibition by these compounds leads to the inhibition of pols and/or topos. From these findings, diacylglyceride phospholipids, which are present in various foods, might be effective nutrients for promoting human anti-cancer health promotion.
Export Options
About this article
Cite this article as:
Ishimaru Chisato, Takeuchi Toshifumi, Sugawara Fumio, Yoshida Hiromi and Mizushina Yoshiyuki, Inhibitory Effects of Diacylglyceride Phospholipids on DNA Polymerase and Topoisomerase Activities, and Human Cancer Cell Growth, Medicinal Chemistry 2010; 6 (3) . https://dx.doi.org/10.2174/1573406411006030114
DOI https://dx.doi.org/10.2174/1573406411006030114 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Monoclonal Antobodies: Application in Radiopharmacy
Current Radiopharmaceuticals Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment
Current Cancer Therapy Reviews Hematopoietic Cell Formation in Leech Wound Healing
Current Pharmaceutical Design Panobinostat: The Small Molecule Metalloenzyme Inhibitor with Marvelous Anticancer Activity
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: The Predictive Pathology in the Target Therapy Era)
Current Drug Targets Pharmacokinetic Properties of Rituximab
Reviews on Recent Clinical Trials Bortezomib: A New Pro-Apoptotic Agent in Cancer Treatment
Current Cancer Drug Targets Evaluating Treatment Response of Chronic Myeloid Leukemia: Emerging Science and Technology
Current Cancer Drug Targets Recent Progress on Tumor Missile Therapy and Tumor Vascular Targeting Therapy as a New Approach
Current Vascular Pharmacology Patents Related to Cancer Stem Cell Research
Recent Patents on DNA & Gene Sequences Therapeutic Peptide Mimetics Looking for a Turn to Block Aberrant Players of Malignancy
Current Cancer Therapy Reviews Biological Markers in Older People at Risk of Mobility Limitations
Current Pharmaceutical Design Clostridium difficile Infection: Associations with Chemotherapy, Radiation Therapy, and Targeting Therapy Treatments
Current Medicinal Chemistry Erythropoietin and mTOR: A “One-Two Punch” for Aging-Related Disorders Accompanied by Enhanced Life Expectancy
Current Neurovascular Research Proteomic Analysis of Aqueous Humor Proteins Associated with Neovascular Glaucoma Secondary to Proliferative Diabetic Retinopathy
Current Proteomics Reversal of Tumor Induced Dendritic Cell Paralysis: A Treatment Regimen Against Cancer
Current Immunology Reviews (Discontinued) ARC - Augmented Renal Clearance
Current Pharmaceutical Biotechnology Review of Airway Illnesses by Kytococcus and Rothia and a Look at Inhalatory Vancomycin as a Treatment Support
Recent Patents on Anti-Infective Drug Discovery Current Treatment Concepts of Philadelphia-Negative MPN
Current Cancer Drug Targets Opposing Functions for the Wilms Tumor Protein 1 (WT1) in Tumorigenesis
Current Pediatric Reviews